<DOC>
	<DOCNO>NCT01293643</DOCNO>
	<brief_summary>This study compare safety efficacy use intravaginal ovule contain combination Ketoconazole Clindamycin use intravaginal cream contain combination Tetracycline Amphotericin B treatment bacterial vaginosis and/or mixed isolated vaginal candidiasis .</brief_summary>
	<brief_title>A Study Compare Efficacy Safety Combination Ketoconazole Clindamycin Compared Tetracycline/Amphotericin B Combination Cream Treatment Bacterial Vaginosis Vaginal Candidiasis ( P08077 )</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Candidiasis , Vulvovaginal</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Diagnosis vaginal candidiasis No Trichomonas vaginalis protozoa No clinical evidence infection Neisseria gonorrhoeae , Chlamydia trachomatis , viral infection Known sensitivity formula component Pregnant nursing patient Any gynecological condition contraindicate use vaginal ovule cream . Use local systemic bactericidal , antiprotozoa antifungal agent within 2 week prior study start Presence sexually transmit disease ( except Candidal vaginitis ) . History recurrent candidiasis ( â‰¥4 episode per year ) Use intrauterine device , spermicide , diaphragm Has metabolic immune disorder Has abnormal uterine bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>